ÂÜÀòÂÒÂ×

Paul Ahlstrom is the CEO of IsoTalent, a technology enabled recruiting service disrupting the industry, as well as the Chairman of Meridian Therapeutics, which produces a novel cancer vaccine. Paul is also a Board Member of Angel Studios, a Managing Director at Alta Ventures, a Co-Founder of TechBuzz.News, an Author of "Nail It Then Scale It," a Co-Founder Partner of Alta Growth Capital, an Advisory Board Member & Mentor at Google Launchpad Accelerator, a Board Member of MURAL, and a Member of the Board of Directors at Juxta Labs. Paul graduated with a BA in Communications from Brigham Young University.